131 related articles for article (PubMed ID: 2403290)
1. Serum carboxylesterase activity in various strains of rats: sensitivity to inhibition by CBDP (2-/o-cresyl/4H:1:3:2-benzodioxaphosphorin-2-oxide).
Clement JG; Erhardt N
Arch Toxicol; 1990; 64(5):414-6. PubMed ID: 2403290
[TBL] [Abstract][Full Text] [Related]
2. The effect of 2-(o-cresyl)-4H-1:3:2-benzodioxaphosphorin-2-oxide on tissue cholinesterase and carboxylesterase activities of the rat.
Jimmerson VR; Shih TM; Maxwell DM; Kaminskis A; Mailman RB
Fundam Appl Toxicol; 1989 Oct; 13(3):568-75. PubMed ID: 2612789
[TBL] [Abstract][Full Text] [Related]
3. Variation between three strains of rat: inhibition of neurotoxic esterase and acetylcholinesterase by tri-o-cresyl phosphate.
Carrington CD; Abou-Donia MB
J Toxicol Environ Health; 1988; 25(3):259-68. PubMed ID: 3184197
[TBL] [Abstract][Full Text] [Related]
4. Effects of three reputed carboxylesterase inhibitors upon rat serum esterase activity.
Chambers JP; Hartgraves SL; Murphy MR; Wayner MJ; Kumar N; Valdes JJ
Neurosci Biobehav Rev; 1991; 15(1):85-8. PubMed ID: 2052204
[TBL] [Abstract][Full Text] [Related]
5. Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.
Yang ZP; Dettbarn WD
Biochem Pharmacol; 1998 May; 55(9):1419-26. PubMed ID: 10076534
[TBL] [Abstract][Full Text] [Related]
6. Assessment of neurotoxic effects of tri-cresyl phosphates (TCPs) and cresyl saligenin phosphate (CBDP) using a combination of in vitro techniques.
Hausherr V; Schöbel N; Liebing J; van Thriel C
Neurotoxicology; 2017 Mar; 59():210-221. PubMed ID: 27288108
[TBL] [Abstract][Full Text] [Related]
7. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity.
Maxwell DM; Brecht KM; O'Neill BL
Toxicol Lett; 1987 Nov; 39(1):35-42. PubMed ID: 3672554
[TBL] [Abstract][Full Text] [Related]
8. Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice.
Clement JG
Biochem Pharmacol; 1984 Dec; 33(23):3807-11. PubMed ID: 6508835
[TBL] [Abstract][Full Text] [Related]
9. Inhibition kinetics of acetylcholinesterase and butyrylcholinesterase from various species by 2-(2-cresyl)-4H-1,3,2-benzodioxaphosphorin-2-oxide (CBDP).
Horn G; Rappenglück S; Worek F
Toxicol Lett; 2024 May; 396():28-33. PubMed ID: 38642675
[TBL] [Abstract][Full Text] [Related]
10. Role of aliesterase in organophosphate poisoning.
Clement JG
Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S96-105. PubMed ID: 6724216
[TBL] [Abstract][Full Text] [Related]
11. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat.
Jimmerson VR; Shih TM; Maxwell DM; Mailman RB
Toxicol Lett; 1989 Jul; 48(1):93-103. PubMed ID: 2749782
[TBL] [Abstract][Full Text] [Related]
12. The interaction of Sertoli and Leydig cells in the testicular toxicity of tri-o-cresyl phosphate.
Chapin RE; Phelps JL; Somkuti SG; Heindel JJ; Burka LT
Toxicol Appl Pharmacol; 1990 Jul; 104(3):483-95. PubMed ID: 2385838
[TBL] [Abstract][Full Text] [Related]
13. A murine model for sarin exposure using the carboxylesterase inhibitor CBDP.
Garrett TL; Rapp CM; Grubbs RD; Schlager JJ; Lucot JB
Neurotoxicology; 2010 Sep; 31(5):502-8. PubMed ID: 20510297
[TBL] [Abstract][Full Text] [Related]
14. A method for generating toxic vapors of soman: toxicity of soman by inhalation in rats.
Aas P; Sterri SH; Hjermstad HP; Fonnum F
Toxicol Appl Pharmacol; 1985 Sep; 80(3):437-45. PubMed ID: 4035697
[TBL] [Abstract][Full Text] [Related]
15. Stereoisomers of soman (pinacolyl methylphosphonofluoridate): inhibition of serum carboxylic ester hydrolase and potentiation of their toxicity by CBDP (2-(2-methylphenoxy)-4H-1,3,2-benzodioxaphosphorin-2-oxide) in mice.
Clement JG; Benschop HP; DeJong LP; Wolthuis OL
Toxicol Appl Pharmacol; 1987 Jun; 89(1):141-3. PubMed ID: 3590185
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human cytochrome P450s involved in the bioactivation of tri-ortho-cresyl phosphate (ToCP).
Reinen J; Nematollahi L; Fidder A; Vermeulen NP; Noort D; Commandeur JN
Chem Res Toxicol; 2015 Apr; 28(4):711-21. PubMed ID: 25706813
[TBL] [Abstract][Full Text] [Related]
17. Hepatic subcellular localization of cresylbenzodioxaphosphorin oxide (CBDP)-sensitive soman binding sites.
Little JS; Maxwell DM; Fox-Talbot MK; Brecht K; Lenz DE
Biochem Pharmacol; 1990 Oct; 40(8):1733-7. PubMed ID: 2242010
[TBL] [Abstract][Full Text] [Related]
18. Effect of pretreatment with CBDP on the toxicokinetics of soman stereoisomers in rats and guinea pigs.
Due AH; Trap HC; Van Der Wiel HJ; Benschop HP
Arch Toxicol; 1993; 67(10):706-11. PubMed ID: 8135661
[TBL] [Abstract][Full Text] [Related]
19. Role of carboxylesterase in soman, sarin and tabun poisoning in rats.
Jokanović M
Pharmacol Toxicol; 1989 Sep; 65(3):181-4. PubMed ID: 2813290
[TBL] [Abstract][Full Text] [Related]
20. Inhibition pathways of the potent organophosphate CBDP with cholinesterases revealed by X-ray crystallographic snapshots and mass spectrometry.
Carletti E; Colletier JP; Schopfer LM; Santoni G; Masson P; Lockridge O; Nachon F; Weik M
Chem Res Toxicol; 2013 Feb; 26(2):280-9. PubMed ID: 23339663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
